YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Transforming Growth Factor Beta-1 in Human Colorectal Cancer Patients

dc.authorscopusid 6504566099
dc.authorscopusid 35332340400
dc.authorscopusid 6504310163
dc.authorscopusid 36477329400
dc.authorscopusid 36476941100
dc.authorscopusid 19033400300
dc.authorscopusid 19033400300
dc.contributor.author Kemik, O.
dc.contributor.author Kemik, A.S.
dc.contributor.author Purisa, S.
dc.contributor.author Hasirci, I.
dc.contributor.author Dülger, A.C.
dc.contributor.author Adaş, M.
dc.contributor.author Tüzün, S.
dc.date.accessioned 2025-05-10T17:07:05Z
dc.date.available 2025-05-10T17:07:05Z
dc.date.issued 2011
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Kemik O., Yuzuncu Yil University Medical Faculty, Department of General Surgery, Van, Turkey; Kemik A.S., Department of Gastroeneterology, Van, Turkey; Purisa S., Istanbul University, Cerrahpasa Medical Faculty, Departments of Biochemistry, Istanbul, Turkey; Hasirci I., Yuzuncu Yil University Medical Faculty, Department of General Surgery, Van, Turkey; Dülger A.C., Departments of Biostatisc, Istanbul, Turkey; Adaş M., Okmeydani Training Hospital, Department of Endocrinology, Istanbul, Turkey; Tüzün S., Haseki Training Hospital, II. General Surgery, Istanbul, Turkey en_US
dc.description.abstract Aim: Colorectal cancer patients are treated with surgery and sometimes radiotherapy and chemotherapy. Transforming growth factor beta-1 (TGF-β1) acts both as an inhibitor of tumor growth and as a promoter of tumor progression. The aim of this study was to determine the levels of TGF-β1 in plasma in colorectal cancer patients and relate these to the effect of clinicopathological variables. Method: One hundred patients scheduled for colorectal cancer surgery were included. Blood samples were taken during surgery and later assayed with enzyme linked immunsorbent assay for total TGF-β1 and active TGF-β1. Result: Total and active TGF-β1 was higher in tumor samples compared to controls (p<0.001).Total TGF-β1 was higher in patients with metastases compared to patients without. Active TGF-β1 levels were not found statistically different in patients with metastases. Conclusion: Higher levels of total TGF-β1 in plasma at surgery may be indicate of distant metastases, Measurement of total TGF-β1 in colorectal cancer patients may be of clinical use in the future. en_US
dc.identifier.doi 10.29333/ejgm/82697
dc.identifier.endpage 56 en_US
dc.identifier.issn 1304-3889
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-79956369765
dc.identifier.scopusquality N/A
dc.identifier.startpage 53 en_US
dc.identifier.uri https://doi.org/10.29333/ejgm/82697
dc.identifier.uri https://hdl.handle.net/20.500.14720/6641
dc.identifier.volume 8 en_US
dc.identifier.wosquality N/A
dc.language.iso tr en_US
dc.publisher TIP ARASTIRMALARI DERNEGI en_US
dc.relation.ispartof European Journal of General Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Colorectal Cancer en_US
dc.subject Distant Metastases en_US
dc.subject Tgf-Beta-1 en_US
dc.title Transforming Growth Factor Beta-1 in Human Colorectal Cancer Patients en_US
dc.type Article en_US

Files